Stem Cell-Derived treatment aims to help stroke patients regain function

NCT ID NCT06759753

Recruiting now Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing whether Aleeto, a treatment derived from stem cell components, can help people recover better after a moderate to severe stroke. Researchers will give 192 participants either Aleeto or a placebo along with standard stroke care to see if it improves movement, thinking, and daily function. The goal is to determine if this experimental treatment is safe and effective for reducing disability after stroke.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Tiantan Hospital
RECRUITING

Beijing, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACUTE ISCHEMIC STROKE